Published in Cancer Weekly, July 31st, 1995
The majority of posttransplantation lymphoproliferative disorders (PTLDs) in bone marrow allograft recipients tend to be of donor origin as the host lymphoid system tends to be ablated by conditioning regimens. However, as few donor lymphoid cells are transferred with a solid organ allograft, it seems that the majority of PTLDs in these patients should be of host origin. The few histological studies done support this trend.
It has been noted, however, that many PTLDs appear preferentially to involve the allograft. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.